Skip to main content
Erschienen in: Translational Stroke Research 1/2015

Open Access 01.02.2015 | Original Article

Seizure Activity Occurs in the Collagenase but not the Blood Infusion Model of Striatal Hemorrhagic Stroke in Rats

verfasst von: Ana C. Klahr, Clayton T. Dickson, Frederick Colbourne

Erschienen in: Translational Stroke Research | Ausgabe 1/2015

Abstract

Seizures are a frequent complication of brain injury, including intracerebral hemorrhage (ICH), where seizures occur in about a third of patients. Rodents are used to study pathophysiology and neuroprotective therapies after ICH, but there have been no studies assessing the occurrence of seizures in these models. Thus, we compared seizure incidence and characteristics after infusing collagenase (0.14 U), which degrades blood vessels, and autologous blood (100 μL) into the striatum of rats. Saline was infused in others as a negative control, whereas iron, a by-product of degrading erythrocytes, served as a positive control. Ipsilateral and contralateral electroencephalographic (EEG) activity was continuously monitored with telemetry probes for a week after the stroke. There were no electrographic abnormalities during baseline recordings. As expected, saline did not elicit any epileptiform activity whereas iron caused seizure activity. Seizures occurred in 66 % of the collagenase group between 10 and 36 h, their duration ranged from 5 to 90 s, and these events were mostly observed bilaterally. No such activity occurred after blood infusion despite comparable lesion sizes of 32.5 and 40.9 mm3 in the collagenase and blood models, respectively (p = 0.222). Therefore, seizures are a common acute occurrence in the collagenase but not whole blood models of striatal ICH (p = 0.028, for incidence). These findings have potential implications for ICH studies such as for understanding model differences, helping select which model to use, and determining how seizures may affect or be affected by treatments applied after stroke.

Introduction

Intracerebral hemorrhage (ICH) occurs in ~15 % of stroke patients, leading to ~50 % mortality and significant disability in survivors [1, 2]. So far, there are no specific neuroprotective therapies for ICH, although survivors benefit from rehabilitation. Thus, it is important to fully understand those factors that affect outcome after ICH in order to improve medical management and further limit death and disability. For instance, seizures are a common occurrence after ICH or even a presenting sign of an ICH. About 4–20 % of ICH patients will suffer from clinical seizures (e.g., convulsions), whereas 30 % of ICH victims will have subclinical seizures observable on an electroencephalogram (EEG; [24]). Current data suggests that the risk of seizures occurring within the first month is 8 % [3], and the risk of a seizure occurring after the first month and within the first year is 3 % [4]. Still, this could be an underestimate caused by the lack of continuous EEG monitoring in patients.
Intuitively, seizures are expected to worsen outcome after an ICH. Seizures can exacerbate excitotoxicity and oxidative stress [5, 6], augment metabolic rate [7], and cause re-bleeding or increased bleeding due to elevated blood pressure and blood flow during seizures [3, 8, 7]. Intracranial pressure (ICP) also rises due to seizures [9], which can cause complications after ICH (e.g., herniation) and increase mortality [2]. Seizures may also cause aberrant brain plasticity (e.g., larger cortical maps) and impair recovery [10]. Lastly, even though the number of ICH patients that develop epilepsy is relatively low (2–5 %), the incidence of one seizure increases the chance of developing epilepsy [2, 4, 3].
All of this illustrates why seizures could be harmful. Clinical studies on this topic, however, have not consistently found that seizures are detrimental [11, 24], although some support this notion [1214]. This variability among clinical studies could be attributed to several factors, such as inclusion criteria, methods for measuring EEG, lack of continuous EEG monitoring, use of anti-epileptic drugs (AEDs), among others. Current guidelines suggest that ICH patients with a depressed mental state should have continuous EEG monitoring, as most seizure activity occurring after ICH is subclinical [24, 15]. Any seizure activity ought to be treated intravenously with an AED, and if seizure activity persists, AED treatment may continue orally. Prophylactic administration of AEDs, however, has been discouraged after evidence from studies indicating a worsening of outcome caused by administration of phenytoin before any signs of seizure activity after not only ICH [15, 16] but also traumatic brain injury [17].
The incidence and consequences of seizures after an ICH have not been well studied in animal models. Thus far, swine studies have shown that excitability increases in certain areas of the brain after ICH [18]. Others have shown that in rodents, the most widely used ICH model, intracerebral infusions of blood components such as thrombin [19] and iron [20] cause seizures. To our knowledge, there have been no formal evaluations of seizure activity in the common rodent models of ICH, which involve injecting autologous blood [21] or collagenase [22] into the brain. Unlike the whole blood injection, bacterial collagenase, an enzyme that breaks down the basal lamina, causes bleeding over hours mimicking what frequently occurs in ICH patients [22, 23]. Often, investigators target the striatum as it is a common site of ICH in humans and because it can contain a large hematoma that results in persistent, easily quantified, behavioral impairments [24]. In this study, we induced a moderate-sized striatal ICH in rats by injecting collagenase or whole blood, and we monitored rats with an implanted EEG telemetry probe for a week after the stroke. By using telemetry, we were able to continuously record EEG in freely moving untethered animals, which is the least stressful method for these animals. The objective of this study was to determine the incidence and characteristics of seizures that occur in these animal models of ICH.

Methods

Subjects

Twenty male Sprague-Dawley rats (250–400 g, ~3 months old) obtained from the Biosciences breeding colony at the University of Alberta were assigned to either the collagenase, whole blood, or saline group. As a positive control, a rat received an injection of FeCl2. Food (Purina rodent chow) and water were provided ad lib and rats were housed individually in a temperature- and humidity-controlled room (lights on from 7 a.m.–7 p.m.).

EEG Probe Implantation

Surgical procedures were performed aseptically. Rats were anesthetized with isoflurane (4 % induction, 1.5–2.5 % maintenance in 60 % N2O, balance O2) and body temperature was maintained at 37 °C during anesthesia with a heated water blanket and a rectal temperature probe. An EEG telemetry probe (F40EET, Data Sciences International, St. Paul, MN) was inserted either in the peritoneal cavity or the neck (dorsal S.C. placement), and the leads were channeled under the skin and attached to screws stereotaxically placed ipsilateral (AP −1.5, ML 4) and contralateral (AP −1.5, ML −4) to the injection site (see Fig. 1). The leads were secured to the screws (0–80 × 3–32; Plastics One, Roanoke, VA) with dental cement. These telemetry probes measure EEG (sampled at 500 Hz, low-pass filtered at 100 Hz) and temperature and movement activity. The latter is detected by changes in signal strength as the probe moves across the receiver (Data Sciences International), providing a relative measure of activity [25].

Iron Injection

As a positive control to assess the ability of the EEG probe to detect seizures, we injected iron in the rat striatum (N = 1). Immediately following attachment of the electrical leads, a hole was drilled (AP 0.5, ML 3.5) and a Hamilton 26-gauge needle was inserted 6.5 mm into the striatum to infuse 38.0 μg of FeCl2 in 30 μL of saline [26, 27]. The injection was completed over 10 min and the needle was removed after an additional 10 min. Clips were used to close the wound. The rat was euthanized 1 week later.

Collagenase, Blood, and Saline Injections

For the saline (N = 3) and five of the collagenase rats (N = 10), a baseline recording period of 1 week was undertaken before the injection. No baseline recording was done for the whole blood rats (N = 6). Following baseline recordings, or directly after the securing of electrical leads, a hole was drilled (AP 0.5, ML 3.5) and a Hamilton 26-gauge needle was inserted 6.5 mm into the striatum. Either saline, 100 μL of autologous whole blood (from tail artery), or 0.14 U of bacterial collagenase in 0.7 μL of sterile saline was infused over 5 or 10 min (blood model) and the needle was removed after an additional 5 or 10 min [23]. Clips were used to close the wound. Saline control and whole blood rats were euthanized after 7 days whereas the collagenase rats were euthanized between 11 and 66 days. This difference in survival times was due to differences in probe placement and technical difficulties that ensued. For instance, probe placements in the neck region caused irritation due to collection of fluid (seroma).

Euthanasia and Lesion Volume Assessment

Rats were injected with sodium pentobarbital (100 mg/kg, i.p.) and then perfused with 0.9 % saline followed by 10 % neutral buffered formalin. Brains were extracted, cryostat-sectioned at 40 μm, and stained with cresyl violet. Coronal sections taken every 200 μm were then analyzed with Image J [28], as routinely done on digitized images extending anterior, through, and posterior to the lesion. The volume of each hemisphere was calculated as follows: (average area of complete coronal section of the hemisphere − area of damage − ventricle) × interval between sections × number of sections [26, 23]. This method takes into account both areas of injury as well as atrophy and ventricular dilation.

EEG Analysis

Baseline and post-infusion EEG traces were visualized with Dataquest A.R.T. 2.3 system (Data Sciences International) and the incidence, duration of seizures, as well as the time to seizure onset from injection were recorded. In three rats, an extended period of 30 days was further analyzed in this way. We compared 5-min epochs of non-epileptiform activity from the day prior to the injection with recordings taken at least 3 days post-stroke from the rats that had a 1-week baseline recording (collagenase N = 4; saline N = 3) in order to detect any changes in otherwise normal-looking EEG. We did not find a significant difference between the day prior to collagenase infusion and day 3 after stroke. Therefore, we considered traces from the third day post-collagenase infusion to be an additional substitute baseline measure for all collagenase rats. Baseline and putative epileptiform traces were exported and analyzed using custom code written in MATLAB (R2012a, Mathworks, Natick, MA). We computed for each signal the root mean square (RMS), the power spectral density using Welch’s averaged modified periodogram method (6-s window, 2-s overlap), as well as dual channel coherence for ipsilateral and contralateral recordings (3-s window; 1-s overlap). Field signals and spectra were plotted for comparison with baseline measures using Origin 9.1 (Microcal Software, Northampton, MA). We compared all putative epileptiform measures, including RMS and 95 % confidence intervals of amplitude fluctuations, to those taken during baseline/control conditions in order to confirm that the events were abnormal. For ictal traces longer than 25 s, power spectra were compared to those baseline traces equal in duration to determine total increases in power, frequencies significantly affected by the seizures, as well as bilateral coherence. A randomized coherence distribution based on a series of sequential time-shifted (and time-reversed) coherence computations from these actual traces was computed to calculate the coherence significance level. The maximum 95 % confidence limit for this randomized distribution (throughout the frequency range) across multiple datasets having durations ranging from 27 to 87 s ranged from 0.22 to 0.061, respectively. In order to determine cross-hemispheric coupling changes during epileptiform activity, we subtracted the coherence values of normal activity from those of epileptic traces and considered that any increases equal to or larger than the confidence limit for that trace was significant. For shorter duration aberrant activity (i.e., interictal spikes), we performed a detection analysis based on a threshold amplitude beyond the amplitude distribution of the normal traces (3.5 standard deviations from the mean [29] and computed the average waveform and number of events occurring per unit time).

Temperature and Activity

We computed temperature averages (F40EET probe) of 5-min periods taken from the hour after the seizure as the difference from the hour prior (e.g., 1 h before seizure average − 5-min temperature average) and statistically analyzed it for comparison. If a seizure occurred in the hour before another seizure, then it was excluded. In the same manner, 1-h activity measures before and following seizure were averaged and compared to assess the impact of seizures on activity (as measured by signal strength changes as the probe moved across the receiver).

Statistical Analysis

Data are presented as mean ± standard deviation (SD) and were analyzed by repeated measures analysis of variance (ANOVA) and student’s t tests (SPSS v.17.0, SPSS Inc., Chicago, IL). The Fisher’s exact test and Mann-Whitney U tests were used to compare between models.

Results

Baseline EEG in the Collagenase Group

Baseline recordings allowed us to relate different behaviors to the EEG traces (Fig. 2), which were helpful for detecting abnormal activity. When we compared the RMS of 5-min traces of the day prior to stroke/sham surgery and days 1, 2, and 3 after the injection of either saline or collagenase (including only those ICH rats with seizures), we found a group (saline vs. collagenase) effect for the ipsilateral channel (p = 0.050, Fig. 3) depicting an increase in RMS in non-epileptic EEG traces after the injection in the collagenase group. This means that the average amplitude fluctuation of traces was higher for the collagenase group even during non-epileptic EEG. Moreover, there was a time effect for the contralateral side (p = 0.028), the RMS on the first day after injection was larger than the third day (p = 0.040) in both groups, although there was no treatment effect.

Seizures After Collagenase and Iron Injection

One collagenase rat had to be excluded due to equipment failure that did not allow for adequate EEG recordings. Six out of the nine remaining rats (66 %) had seizures within the first 2 days after the stroke with the earliest occurring after ~10 h and the latest occurring after ~36 h. Seizures ranged in duration from ~5 to 90 s, and their averages ranged from 14 to 54 s (Table 1, Fig. 4b–d). Iron also caused seizures within hours of application (Fig. 4a), which displayed a similar pattern of tonic-clonic ictal events followed by notable EEG suppression and occasional afterdischarges. Seizures or other electrographic abnormalities were not observed in any of the six rats infused with 100 μL of autologous blood (p = 0.028 for comparing number of rats with seizures between models). Not surprisingly, both the number (p = 0.036) and duration of seizures (p = 0.036) were significantly greater in the collagenase model.
Table1
Characteristics of seizures after collagenase-induced ICH. EEG activity occurring in the first week after collagenase injection were visualized and analyzed. These are the characteristics for the seizures that occurred within the first 36 h after the stroke; no seizures were detected afterwards. For each rat, the number of seizures, laterality, total duration, and time of onset were documented. We also reported other factors to determine the variability of the traces as depicted by the RMS ratio (RMS seizure/RMS non-epileptic activity) and changes in voltage according to their frequency, as depicted by the power increased and frequencies affected. Also, for those frequencies in which the power was affected, coherence was assessed as an indicator of how coupled the activity was in between both channels. Here, coherence was computed as an increase from baseline coherence. Traces shorter than 25 s were not analyzed for power and coherence. Data expressed as M ± SD
ID
Incidence
Laterality
Total duration (s)
Time of onset after ICH
RMS ratio
Frequencies affected (Hz)
Power increase (mV2)
Coherence change
1
1
Ipsilateral
14
11 h, 52 min
2.44
N/A
N/A
N/A
2
2
Bilateral
102 (51 ± 19.80)
18 h, 50 min
1.9 ± 0.33
↑ 0–4.6
34.11 ± 14.66
−0.53 ± 0.11
3
3
Bilateral
163 (54.33 ± 35.57)
22 h, 7 min
1.92 ± 0.29
↓ 0.5–0.94,
↑1.32–1.5,
↑ 1.78–5.8,
↑12.38–38
16.40 ± 5.23
−0.19 ± 0.10a, 0.14 ± 0.16
4
4
Bilateral
108 (27 ± 4.9)
16 h, 25 min
2.65 ± 0.23
↑ 1.07–6.2
16.01 ± 3.99
0.34 ± 0.022
5
8
Bilateral
173 (21.62 ± 17.76)
11 h, 37 min
4.13 ± 0.43
↑ 0–39.9
71.03 ± 14.57
0.42 ± 0.19
6
14
Bilateral
616 (44 ± 46.24)
9 h, 57 min
2.53 ± 0.53
↑ 0–47
33.77 ± 16.07
0.24 ± 0.025
aOccurring in frequencies below 5.8 Hz
In two collagenase rats, we detected extended periods of interictal epileptiform discharges, ranging from ~1.5 to 14 h (Fig. 5). Over the span of 30 min in which seizures occurred in one animal, we detected abnormal interictal events in between obvious ictal activity. Interictal activity did not last more than 2 min; therefore, we were not able to analyze them using our event detection analysis due to their short duration. For the three rats in which 30 days of EEG were screened, two had seizures within 36 h, but none of them had any noticeable EEG abnormalities after that period. Therefore, none of our collagenase rats appeared to have developed epilepsy per se. Most of the seizures were bilateral, which were likely generalized from an initiation zone located in the affected hemisphere and propagated across contralateral hemisphere. There was only one case in which the seizure activity occurred only ipsilaterally (Table 1).

Severity of Seizures in the Collagenase Group

We calculated RMS and quantified power increases of seizure traces and compared them to non-epileptic activity taken from day 3 post-collagenase surgery as an indicator of increases in amplitude at different frequencies (power) and fluctuations in the amplitude (RMS) of the ictal events. The smallest RMS-fold increase for the ipsilateral side was 1.58 times larger than non-epileptiform activity, and the largest was 4.69 times larger during ictal activity. Similarly, for the contralateral side, the smallest epileptiform RMS was 1.45 times larger, and the largest was 4.96 larger. This indicates that during seizure activity, there was about a 50–500 % increase in amplitude fluctuations in these traces. In general, increases in power were seen at all frequencies up to 38 Hz, with a decrease in frequencies across the 0.5–5.8 Hz bandwidth detected in a single rat (Table 1). Also, in most cases, the ipsilateral channel had an equal or greater increase in power than the contralateral, although this was not the case for two rats. This could support the notion of an ipsilateral focus that propagates, and/or generalizes, to the contralateral hemisphere.
For coherence calculations, we concentrated on increases in coherence at the frequencies in which we noted a change in power. Coherence values range from 0 to 1; values of 0 indicating that signal-specific frequencies between the two channels are completely unrelated, whereas values of 1 indicate that they are completely related. In most instances, we found significant increases in cross-hemispheric coherence during epileptiform activity as compared to normal traces taken 3 days after the collagenase injection (average increase across frequencies 0.28 ± 0.14). Two cases showed exceptions to this rule, one in which no increase was observed and another in which coherence values were significantly decreased despite prominent bilateral seizure activity in both cases. In one rat, we also detected that coherence was decreased for frequencies lower than 6 Hz but that for higher frequencies coherence was increased. Indeed, increases in power for higher frequencies (12–40 Hz) during seizure events were all associated with significantly increased coherence (see example in Fig. 6). This might indicate that the more severe seizures were, the more likely that both hemispheres were engaged in epileptic activity.

Lesion Volume

The infusion of collagenase or blood caused significant damage and inflammation, as depicted in Fig. 7a (p = 0.22 for lesion volume). In the collagenase model, we found no significant relationships between lesion volume and seizure incidence (r = 0.18, p = 0.65; see Fig. 7b), time of onset after stroke (r = 0.30, p = 0.56), total (r = 0.37, p = 0.31) and average time spent in seizure activity (r = 0.18, p = 0.63), RMS (r = 0.18, p = 0.65), and power increase (r = 0.29, p = 0.63). Thus, we did not find that lesion volume predicted seizure characteristics in this model. Owing to the lack of seizure activity, we did not perform this analysis with the whole blood model data.

Temperature and Activity Data

A repeated measures ANOVA did not depict a difference among the twelve 5-min average intervals (i.e., 1 h) following the seizure (p = 0.382), indicating that there were no changes in temperature after the seizure. Even though there was no pattern in the temperature change among rats, one rat had a seizure leading to about 90 min of hypothermia (Fig. 8). Moreover, a paired t test on all of the rats’ movement activity indicated no difference between activity before and after the seizure (p = 0.7968).

Discussion

We expected seizures to occur in the blood infusion model, but this was not observed. Our results did confirm our hypothesis that seizures commonly occur after striatal ICH in the collagenase model. Sixty-six percent of rats in the collagenase group suffered seizures during the first 36 h following their stroke. Seizures commonly occur after brain injury and stroke, both in patients [30, 2, 31] and in other animal models of brain injury [3234]. Thus, it is not surprising that collagenase rats would also display abnormal electrical activity as we demonstrated in this study, including both full-blown ictal and abnormal interictal activity, which mostly occurred bilaterally. Increased cross-hemispheric coherence coinciding with increased power suggests that the activity in both hemispheres during seizure activity was coupled and that more severe seizures recruited both hemispheres. Although there were some exceptions to this, coherence remained significantly increased, especially at the higher frequencies. We also demonstrated that even normal-looking electrical activity has an increased RMS for the first 3 days after collagenase-induced ICH, which could indicate that there were abnormalities in non-epileptic EEG activity during this limited time frame. Although robust epileptiform activity was a consistent phenomenon in our collagenase group, we did not find lesion volume to be a predictor for any of the seizure characteristics. Likewise, the lack of seizures in the blood model, which had a comparable lesion, argues against lesion or hematoma volume as key predictors of seizure activity.
The incidence of electrographic seizures in our collagenase group (66 %) is more than double that documented in ICH patients [2]. The difference in incidence might be attributed to the greater range in patient characteristics (e.g., ICH locations, severity) in clinical studies, along with other factors such as species differences. Interestingly, other pre-clinical studies of brain insults, namely, hypoxic-ischemic injury [33], focal ischemia [34], and traumatic brain injury [32], all report a much higher percentage of animals developing seizures and epilepsy than what is reported in the clinic. However, continuous monitoring of EEG for many weeks or months is rare in clinical studies, making it difficult to compare animal and clinical data.
There are key differences between the collagenase and whole blood models that may explain the discrepancy in seizure incidence between these models. For instance, the whole blood model of ICH provides a somewhat different profile of injury (see Fig. 7a) with less secondary injury, inflammation, blood brain barrier damage, and smaller intracranial pressure spikes [23, 35, 36], but these may vary by species [37]. As with inflammation [38], it is possible that the timing, extent, and localization of thrombin production vary between models and this might account for differences in seizure activity. Note that intracerebral infusions of thrombin induce seizure activity [19]. Iron infusions also cause epileptogenic activity [20], as we presently confirmed. However, given the timing of iron release, which in our collagenase model occurs between 24 and 72 h [39], it is unlikely that iron causes seizures as they began between 10 and 22 h, and stopped by 36 h. As well, the hematoma volume is expected to be larger in rats infused with 100 μL of blood than those given collagenase [23]. Thus, if iron were the primary cause of seizures, there should have been more seizures in the whole blood model.
Early seizures are predictors of future epilepsy in stroke patients [13], although a study by Bladin and colleagues [4] showed that all of the patients that had late onset seizures, which were those at 2 or more weeks after the stroke, developed epilepsy. We did not find recurrent seizures after the first 36 h of the stroke, even though we screened EEG for up to a month after collagenase infusion. While this suggests that this model does not lead to epilepsy, a much larger sample size is needed especially given the small percentage expected to develop that condition. There is also the possibility that seizures may develop later than a month after ICH in rats, as occurs in other animal models such as traumatic brain injury [32].
There are some limitations to this study. First, we did not video record any of the seizure events, so the type of behavioral manifestations with these electrographic seizures remains unknown. Although, we occasionally noticed behavioral signs of focal seizures, such as clonic paw movements. Second, the relatively limited number of animals in this study cannot exclude the possibility that occasional seizure activity occurs in the whole blood model. Third, with larger sample sizes, a modest relationship between lesion volume and seizure characteristics may have been detected. Indeed, others have reported a relationship between epileptiform activity and infarct size after focal ischemia [40]. In a clinical study, however, small lesion size was a better predictor of seizure incidence [3]. Fourth, while we recommend use of telemetry probes, tethered systems have the advantage of allowing monitoring from more locations, which would be advantageous in future studies (e.g., to identify seizure focus). The use of telemetry probes also had some additional disadvantages (e.g., greater cost) including technical problems we encountered with the use of lead extenders and of course the inevitable loss of battery power. Lastly, while EEG eventually returned to normal, it is likely that seizure thresholds were altered as found in traumatic brain injured rats given a pro-convulsant challenge [32].
Further studies should be carried out to advance our knowledge of seizures occurring after ICH. Seizure incidence should be studied after changing the location of the lesion, as lobar/cortical location has been associated with more seizure activity in patients [3, 4]. Even though the striatal model of ICH is a common one, other structures have also been targeted, such as cortex [18] and hippocampus [41], and we are presently evaluating these models. It is possible that whole blood injections in different locations may elicit seizure activity. Also, patients with an ICH also have increased ICP after the insult [15], which is also common after a collagenase-induced ICH in rats [36]. This sustained rise in ICP could be associated either to the mass effect arising from the hematoma and edema or to seizure activity, which could especially be related to ICP spiking [9]. This could be elucidated by simultaneous EEG and ICP monitoring. Furthermore, future research should focus on the relationship between seizures, cell death, and recovery. Some clinical studies have related seizures with worsened outcome and mortality [1214], although others failed to do so [11, 24]. In animal models, we can experimentally increase seizure activity with convulsant drugs or diminish it with AEDs and test its impact on several markers of cell death (e.g., neurodegeneration) and functional outcome.
In conclusion, seizures occur in the majority of rats subjected to a collagenase-induced striatal ICH but did not occur after infusion of whole blood—models widely used to study the pathophysiology of ICH and to assess neuroprotectants and rehabilitation therapies [35]. As ICH patients also suffer from seizures early after the stroke, the rat collagenase model has good face validity to model seizures occurring after ICH, although further work is needed to determine whether the underlying cause is the same as in patients. This is a key factor for translational purposes, as others have raised concerns regarding differences between animal and human ICH pathophysiology [42, 43, 35, 4446]. Researchers should also consider that seizures could potentially impact their studies. For instance, seizure activity may exacerbate the damage caused by the stroke, altering the effectiveness of neuroprotective therapies. Also, treatments may indirectly reduce cell death by ameliorating seizure activity. We recommend the use of the whole blood model when seizures may be a confounding factor. As this is the first study to find that seizures occur after collagenase-induced ICH in rats, we encourage further research to understand the relationship between seizures, cell death, and recovery after ICH. This way, we will be able to enhance therapies currently provided to ICH patients.

Acknowledgments

The research is supported by the Canadian Institutes of Health Research to Dr. Colbourne, who was a Senior Medical Scholar of Alberta Innovates—Health Solutions and is currently a Canada Research Chair in Intracerebral Hemorrhagic Stroke. The authors thank Yonglie Ma for the surgical assistance.

Conflict of Interest

Ana Klahr, Clayton Dickson, and Frederick Colbourne declare that they have no conflict of interest.

Compliance with Ethics Requirements

All institutional and national guidelines for the care and use of laboratory animals were followed. Specifically, procedures followed the guidelines of the Canadian Council of Animal Care and were approved by the Biosciences Animal Care and Use Committee at the University of Alberta.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Broderick JP, Phillips SJ, Whisnant JP, O'Fallon WM, Bergstralh EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke. 1989;20(5):577–82.PubMedCrossRef Broderick JP, Phillips SJ, Whisnant JP, O'Fallon WM, Bergstralh EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke. 1989;20(5):577–82.PubMedCrossRef
3.
Zurück zum Zitat Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43(10):1175–80.PubMedCrossRef Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43(10):1175–80.PubMedCrossRef
4.
Zurück zum Zitat Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Cote R, etal. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57(11):1617–22. Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Cote R, etal. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57(11):1617–22.
7.
Zurück zum Zitat Meldrum BS, Nilsson B. Cerebral blood flow and metabolic rate early and late in prolonged epileptic seizures induced in rats by bicuculline. Brain. 1976;99(3):523–42.PubMedCrossRef Meldrum BS, Nilsson B. Cerebral blood flow and metabolic rate early and late in prolonged epileptic seizures induced in rats by bicuculline. Brain. 1976;99(3):523–42.PubMedCrossRef
8.
Zurück zum Zitat Goodman JH, Homan RW, Crawford IL. Kindled seizures elevate blood pressure and induce cardiac arrhythmias. Epilepsia. 1990;31(5):489–95.PubMedCrossRef Goodman JH, Homan RW, Crawford IL. Kindled seizures elevate blood pressure and induce cardiac arrhythmias. Epilepsia. 1990;31(5):489–95.PubMedCrossRef
9.
Zurück zum Zitat Vespa PM, Miller C, McArthur D, Eliseo M, Etchepare M, Hirt D, etal. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med. 2007;35(12):2830–6. Vespa PM, Miller C, McArthur D, Eliseo M, Etchepare M, Hirt D, etal. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med. 2007;35(12):2830–6.
11.
Zurück zum Zitat Alberti A, Paciaroni M, Caso V, Venti M, Palmerini F, Agnelli G. Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag. 2008;4(3):715–20.PubMedCentralPubMed Alberti A, Paciaroni M, Caso V, Venti M, Palmerini F, Agnelli G. Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag. 2008;4(3):715–20.PubMedCentralPubMed
12.
Zurück zum Zitat Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E. Predictive factors of early seizures after acute cerebrovascular disease. Stroke. 1997;28(8):1590–4.PubMedCrossRef Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E. Predictive factors of early seizures after acute cerebrovascular disease. Stroke. 1997;28(8):1590–4.PubMedCrossRef
13.
15.
Zurück zum Zitat Morgenstern LB, Hemphill 3rd JC, Anderson C, Becker K, Broderick JP, Connolly Jr ES, etal. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29. doi:10.1161/STR.0b013e3181ec611b. Morgenstern LB, Hemphill 3rd JC, Anderson C, Becker K, Broderick JP, Connolly Jr ES, etal. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29. doi:10.​1161/​STR.​0b013e3181ec611b​.
16.
Zurück zum Zitat Naidech AM, Garg RK, Liebling S, Levasseur K, Macken MP, Schuele SU, etal. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40(12):3810–5. doi:10.1161/STROKEAHA.109.559948. Naidech AM, Garg RK, Liebling S, Levasseur K, Macken MP, Schuele SU, etal. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40(12):3810–5. doi:10.​1161/​STROKEAHA.​109.​559948.
19.
Zurück zum Zitat Lee KR, Drury I, Vitarbo E, Hoff JT. Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg. 1997;87(1):73–8.PubMedCrossRef Lee KR, Drury I, Vitarbo E, Hoff JT. Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg. 1997;87(1):73–8.PubMedCrossRef
21.
Zurück zum Zitat Bullock R, Mendelow AD, Teasdale GM, Graham DI. Intracranial haemorrhage induced at arterial pressure in the rat. Part 1: description of technique, ICP changes and neuropathological findings. Neurol Res. 1984;6(4):184–8.PubMed Bullock R, Mendelow AD, Teasdale GM, Graham DI. Intracranial haemorrhage induced at arterial pressure in the rat. Part 1: description of technique, ICP changes and neuropathological findings. Neurol Res. 1984;6(4):184–8.PubMed
22.
Zurück zum Zitat Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke. 1990;21(5):801–7.PubMedCrossRef Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke. 1990;21(5):801–7.PubMedCrossRef
23.
Zurück zum Zitat MacLellan CL, Silasi G, Poon CC, Edmundson CL, Buist R, Peeling J, etal. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab. 2008;28:516–25. doi:10.1038/sj.jcbfm.9600548. MacLellan CL, Silasi G, Poon CC, Edmundson CL, Buist R, Peeling J, etal. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab. 2008;28:516–25. doi:10.​1038/​sj.​jcbfm.​9600548.
24.
Zurück zum Zitat MacLellan CL, Auriat AM, McGie SC, Yan RH, Huynh HD, De Butte MF, etal. Gauging recovery after hemorrhagic stroke in rats: implications for cytoprotection studies. J Cereb Blood Flow Metab. 2006;26:1031–42. MacLellan CL, Auriat AM, McGie SC, Yan RH, Huynh HD, De Butte MF, etal. Gauging recovery after hemorrhagic stroke in rats: implications for cytoprotection studies. J Cereb Blood Flow Metab. 2006;26:1031–42.
25.
Zurück zum Zitat Colbourne F, Auer RN, Sutherland G. Characterization of postischemic behavioral deficits in gerbils with and without hypothermic neuroprotection. Brain Res. 1998;803:69–78.PubMedCrossRef Colbourne F, Auer RN, Sutherland G. Characterization of postischemic behavioral deficits in gerbils with and without hypothermic neuroprotection. Brain Res. 1998;803:69–78.PubMedCrossRef
27.
Zurück zum Zitat Nakamura T, Keep RF, Hua Y, Nagao S, Hoff JT, Xi G. Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. Acta Neurochir Suppl. 2006;96:194–8.PubMedCrossRef Nakamura T, Keep RF, Hua Y, Nagao S, Hoff JT, Xi G. Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. Acta Neurochir Suppl. 2006;96:194–8.PubMedCrossRef
28.
Zurück zum Zitat Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–5.PubMedCrossRef Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–5.PubMedCrossRef
31.
Zurück zum Zitat Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke. 2004;35(7):1769–75.PubMedCrossRef Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke. 2004;35(7):1769–75.PubMedCrossRef
32.
Zurück zum Zitat Bolkvadze T, Pitkanen A. Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse. J Neurotrauma. 2012;29(5):789–812. doi:10.1089/neu.2011.1954.PubMedCrossRef Bolkvadze T, Pitkanen A. Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse. J Neurotrauma. 2012;29(5):789–812. doi:10.​1089/​neu.​2011.​1954.PubMedCrossRef
34.
Zurück zum Zitat Hartings JA, Williams AJ, Tortella FC. Occurrence of nonconvulsive seizures, periodic epileptiform discharges, and intermittent rhythmic delta activity in rat focal ischemia. Exp Neurol. 2003;179(2):139–49.PubMedCrossRef Hartings JA, Williams AJ, Tortella FC. Occurrence of nonconvulsive seizures, periodic epileptiform discharges, and intermittent rhythmic delta activity in rat focal ischemia. Exp Neurol. 2003;179(2):139–49.PubMedCrossRef
35.
Zurück zum Zitat MacLellan CL, Paquette R, Colbourne F. A critical appraisal of experimental intracerebral hemorrhage research. J Cereb Blood Flow Metab. 2012;32:612–7.PubMedCentralPubMedCrossRef MacLellan CL, Paquette R, Colbourne F. A critical appraisal of experimental intracerebral hemorrhage research. J Cereb Blood Flow Metab. 2012;32:612–7.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Barratt HE, Lanman TA, Carmichael ST. Mouse intracerebral hemorrhage models produce different degrees of initial and delayed damage, axonal sprouting, and recovery. J Cereb Blood Flow Metab. 2014. doi:10.1038/jcbfm.2014.107.PubMed Barratt HE, Lanman TA, Carmichael ST. Mouse intracerebral hemorrhage models produce different degrees of initial and delayed damage, axonal sprouting, and recovery. J Cereb Blood Flow Metab. 2014. doi:10.​1038/​jcbfm.​2014.​107.PubMed
39.
Zurück zum Zitat Auriat AM, Silasi G, Wei Z, Paquette R, Paterson P, Nichol H, etal. Ferric iron chelation lowers brain iron levels after intracerebral hemorrhage in rats but does not improve outcome. Exp Neurol. 2012;234:136–43. doi:10.1016/j.expneurol.2011.12.030. Auriat AM, Silasi G, Wei Z, Paquette R, Paterson P, Nichol H, etal. Ferric iron chelation lowers brain iron levels after intracerebral hemorrhage in rats but does not improve outcome. Exp Neurol. 2012;234:136–43. doi:10.​1016/​j.​expneurol.​2011.​12.​030.
40.
41.
Zurück zum Zitat Song S, Hua Y, Keep RF, He Y, Wang J, Wu J, etal. Deferoxamine reduces brain swelling in a rat model of hippocampal intracerebral hemorrhage. Acta Neurochir Suppl. 2008;105:13–8. Song S, Hua Y, Keep RF, He Y, Wang J, Wu J, etal. Deferoxamine reduces brain swelling in a rat model of hippocampal intracerebral hemorrhage. Acta Neurochir Suppl. 2008;105:13–8.
42.
Zurück zum Zitat Adeoye O, Clark JF, Khatri P, Wagner KR, Zuccarello M, Pyne-Geithman GJ. Do current animal models of intracerebral hemorrhage mirror the human pathology? Transl Stroke Res. 2010;in press. Adeoye O, Clark JF, Khatri P, Wagner KR, Zuccarello M, Pyne-Geithman GJ. Do current animal models of intracerebral hemorrhage mirror the human pathology? Transl Stroke Res. 2010;in press.
46.
Zurück zum Zitat Ninds ICH Workshop. Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke. 2005;36(3):e23–41.CrossRef Ninds ICH Workshop. Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke. 2005;36(3):e23–41.CrossRef
Metadaten
Titel
Seizure Activity Occurs in the Collagenase but not the Blood Infusion Model of Striatal Hemorrhagic Stroke in Rats
verfasst von
Ana C. Klahr
Clayton T. Dickson
Frederick Colbourne
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Translational Stroke Research / Ausgabe 1/2015
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-014-0361-y

Weitere Artikel der Ausgabe 1/2015

Translational Stroke Research 1/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.